RADT-25. EVALUATING LYMPHOCYTE COUNTS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION

BACKGROUND: Glioblastoma (GBM) patients are treated with chemotherapy, radiation therapy (RT) and often corticosteroids, which can all contribute to lymphopenia. We examined lymphopenia with respect to incidence, predictors, and association with progression-free survival (PFS) and overall survival (...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Hammoudeh, Lubna, Lim-Fat, Mary Jane, Cagney, Daniel, Aizer, Ayal A, Tanguturi, Shyam, Arvold, Nils, Mcfaline-Figueroa, Jose, Chukwueke, Ugonma, Reardon, David, Lee, Eudocia, Nayak, Lakshmi, Rinne, Mikael, Ligon, Keith, Wen, Patrick, Alexander, Brian, Rahman, Rifaquat
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Clinical Radiotherapy
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651411/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.778
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller